Showing results (461-470 of 476) with videos related to

Sort By:
Pageof 48
Urology|March 3, 2018
The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor ThrombusRyan Hutchinson, Charles Rew, Gong Chen, et al.
Urology|February 9, 2024
Gender-based Disparity Exists in the Surgical Experience of Female and Male Urology ResidentsKathryn A Marchetti, Charles A Ferreri, Emma C Bethel, et al.
Developmental Cell|July 12, 2020
PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell DifferentiationJeanette A Johansson, Kerrie L Marie, Yuting Lu, et al.
Human Pathology|November 18, 2023
Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic diseaseSarwat I Gilani, Surendra Dasari, Burak Tekin, et al.
Human Pathology|November 17, 2023
Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinomaBurak Tekin, John C Cheville, Loren Herrera Hernandez, et al.
Mayo Clinic Proceedings|June 26, 2022
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling InhibitorsSounak Gupta, Paige Nichols, Christine M Lohse, et al.
Human Pathology|June 23, 2024
High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: A single institution experienceBurak Tekin, Antonio L Cubilla, John C Cheville, et al.
Human Pathology|April 2, 2021
Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencingC Eric Freitag, William R Sukov, Alan H Bryce, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical managementSounak Gupta, John C Cheville, Achim A Jungbluth, et al.
The Journal of Clinical Investigation|February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaNiraj Shenoy, Tushar D Bhagat, John Cheville, et al.
Pageof 48